Theialife
Manufacturing · United Arab Emirates · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Burjuman Office Tower Office L23/05-12 F...Phone Number
+91 8028410158Website
www.theialife.comRevenue
<$5 MillionIndustry
About Theialife
Theialife is a U.S. incorporated, late-stage clinical ophthalmology company dedicated to developing innovative therapies for ocular diseases, particularly focusing on pediatric myopia. Their lead asset, ND10, is the world's first oral therapy for early-onset pediatric myopia, set to enter global Phase III clinical trials in 2026. The company aims to transform standards of care and improve patients' lives through cutting-edge treatments that prevent sight deterioration and restore vision. With a commitment to addressing unmet needs in global ophthalmology, Theialife leverages a proprietary platform to advance unique therapies and formulations.Explore more
Theialife Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Theialife Tech Stack
A closer look at the technologies used by Theialife
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Theialife
Sign Up For FreeTo access detailed company insights
Theialife is a U.S. incorporated, late-stage clinical ophthalmology company dedicated to developing innovative therapies for ocular diseases, particularly focusing on pediatric myopia. Their lead asset, ND10, is the world's first oral therapy for early-onset pediatric myopia, set to enter global Phase III clinical trials in 2026. The company aims t... Read More
